MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Health-related quality of life in cervical dystonia; the hidden and unaddressed effect of anxiety

    I. Ndukwe, P. Lynch, J. Dover, C. O’Neill, F. O’Keeffe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: The aim of this study was to assess health-related quality of life in patients with cervical dystonia and assess factors considered to contribute to…
  • 2019 International Congress

    Descriptive Presentation of MRI Findings in Multiple Sclerosis Patients with Tonic Spasm

    M. Salari, M. Etemadifar, SH. Ghourchian (Tehran, Islamic Republic of Iran)

    Objective: It may provide a better gathering of data for further Meta-analyses regarding factors associated with tonic spasm in MS. Background: The lower prevalence of…
  • 2019 International Congress

    Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience

    V. Veerappan, M. Brodsky (Portland, OR, USA)

    Objective: To describe characteristics of patients with secondary limb dystonia in Parkinson’s Disease, types of dystonia observed, and treatment/response with chemodenervation. Background: Dystonia can be…
  • 2019 International Congress

    An examination of real-world onabotulinumtoxinA utilization for the treatment of upper limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

    G. Francisco, G. Bavikatte, W. Jost, D. Bandari, S. Tan Tang, A. Zuzek, A. Patel, J. Largent, A. Esquenazi (Taoyuan, Taiwan)

    Objective: To explore real-world patterns of onabotulinumtoxinA utilization in patients with upper limb spasticity over 2 years. Background: OnabotulinumtoxinA treatment for spasticity is variable, as…
  • 2019 International Congress

    Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers

    I. Malaty, D. Shineman, W. Deeb (Gainesville, FL, USA)

    Objective: To explore diagnosis and treatment experiences in a “real world” sample of Tourette syndrome and tic disorders. Background: Tourette syndrome (TS) is a complex,…
  • 2019 International Congress

    Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor

    MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, RC. Helmich (Nijmegen, Netherlands)

    Objective: To disentangle the cerebral mechanisms underlying dopamine-resistant versus dopamine-responsive tremor in Parkinson’s disease. Background: Parkinson’s rest tremor is related to cerebral activity in both…
  • 2019 International Congress

    Overnight unilateral withdrawal of VIM-DBS to identify reversibility of gait disturbances

    D. Kroneberg, D. Kübler, B. Al-Fatly, AC. Meyer, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: This study aims to improve clinical applicability, patient comfort and safety of stimulation withdrawal to differentiate stimulation-induced side effects from disease progression. Background: Gait…
  • 2019 International Congress

    Improvement of lower extremity Holmes tremor with intrathecal baclofen: First Report

    S. Saad, C. Kilbane, H. Abboud (Cleveland, OH, USA)

    Objective: OBJECTIVE: To describe a novel response of Atypical Holmes tremor to intrathecal baclofen (ITB). Background: Holmes tremor is a rare low-frequency high-amplitude tremor predominantly…
  • 2019 International Congress

    The dopamine receptor antagonist haloperidol enhances beta and gamma oscillations and bursts in the motor cortex

    M. Alam, T. Doll, J. Krauss, K. Schwabe (Hannover, Germany)

    Objective: We aimed to investigate the changes in oscillatory activity in the motor cortex (MCtx) and the sensorimotor cortex (SMCtx) of rats after acute injection…
  • 2019 International Congress

    Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome

    S. Raju, K. Vyas (Bangalore, India)

    Objective: To report a case of clonazepam induced withdrawal emergent dyskinesia. Background: Withdrawal emergent syndrome was first described in 1973 when it was noticed that…
  • « Previous Page
  • 1
  • …
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley